Innovation and strategies for pharmas, biotechs and the R&D community
• 1982 – 1987 - Medicine, Universidade Estadual Paulista (UNESP).<br> • 1988 – 1989 – Residency in Internal Medicine HC – UNESP<br> • 1989 – 1991 - Residency in Gastroenterology HC Universidade São Paulo USP<br> • 2007 – 2010 – Executive MBA – S&#…more ›
Graduated in Economy at the University of São Luis, S.Paulo, post graduation in Marketing at the FGV and Business Management from Don Cabral Foundation. Broad knowledge in generics in Brazil, have been working in sales since the beginning of the generic.Participa…more ›
Graduado em Ciências Farmacêuticas pela PUC-Campinas. Foi professor na Faculdade de Farmácia da PUC-Campinas nos anos de 1990 e 2000. Foi Conselheiro do CFF em 1992. Diretor Vice-Presidente e depois Presidente do CRF do Estado de São Paulo, entre 199…more ›
Odnir Finotti is the Executive President and current CEO of ProGenericos. Mr. Finotti has been working in the pharmaceutical industry for over 30 years, including 15 years as CEO for multinational companies like ASTA Medica, Schering-Plough and Mepha Brasil. Founded in…more ›
Mauricio Joffily Pereira da Costa Pinheiro is graduated in Law at PUC/SP (Catholic University of São Paulo – Brazil), with specialization in Intellectual Property and Tax and post-graduating degree in business management from FGV. Mauricio is currently at the Lega…more ›
Latin America’s leading generic drug manufacturing conference
The World Generics Congress LatAm is where international and regional generic drug manufacturers, biosimilars developers, CMOs, government, pharma, biotech and bioequivalence testing services gather to discuss the opportunities and challenges behind generic drug development in Latin America.
Join senior level attendees from regional pharmas and governments driving generic drug manufacture to improve access to affordable healthcare, to international generics manufacturers looking to tap into Latin American pharma markets.
Co-located with the Biopharma LatAm Convention, this is the leading event to attend if you’re looking for generic drug development and manufacturing opportunities throughout Latin America.
Come to the World Generics Congress LatAm to learn:
- How to identify indications and products most suited for generic drug development
- How to work with governments who are incentivizing and driving generic drug development
- How to identify and meet regional regulatory requirements for generic drugs
- How to source and implement partnerships/buy-outs with regional generics manufacturers
- How to adapt biosimilars business models to the Latin American markets
- How to improve bioequivalence, safety and efficacy of generics in Latin America
- How to overcome language discrepancies identifying genetic drug criteria throughout Latin America
Who should sponsor?
- Contract manufacturing services
- Bioequivalence testing services
- Generic drug consulting services
What to expect in 2012:
- Sustainability of healthcare in Latin America
- Market review for generics in Latin America
- Government responsibility and role in generic drug development
- Regional regulatory policy
- Development trends and target indications
- Biosimilars in Latin America
Co-located with the Biopharma LatAm Convention:
- Drug Discovery World LatAm
- Pharma Trials World LatAm
- Exhibition hall and 12+ hours of dedicated shared networking
